TrialEuropean heart journal2021

Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants.

Jackie Bosch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.